Results 131 to 140 of about 11,886 (196)

Beyond Vaccination: Persistent Meningococcal Risk in Anti-C5-Treated aHUS-Case Report and Review of Literature. [PDF]

J Clin Med
Matarese S, Brisca G, Moscatelli A, Romanengo M, Mesini A, Mariani M, Mortari G, Castagnola E, Gentile M, Verrina E, Ardissino G, La Porta E.   +11 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry. [PDF]

Am J Hematol
Röth A, Patriquin CJ, Szer J, Terriou L, Patel AS, Metzger J, Gustovic P, Nishimura JI, Brodsky RA.   +8 more
europepmc   +1 more source

Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107. [PDF]

Blood Adv
europepmc   +1 more source

Perioperative use of eculizumab in patients with thymoma-associated myasthenia gravis: A preliminary case series of five patients. [PDF]

IBRO Neurosci Rep
Ou Y, Wen Y, Liu Y, Lai M, Wang H, Chen X, Zhang H, Peng Y.   +7 more
europepmc   +1 more source

Optimizing Care in Patients with Paroxysmal Nocturnal Hemoglobinuria: Managing Suboptimal Response and Uncontrolled Disease. [PDF]

J Blood Med
Bienz M, Oliver M, Sperlich C, Patriquin CJ.   +3 more
europepmc   +1 more source

Differential complement activation by alloantibodies in sickle cell hyperhaemolysis syndrome may influence disease course. [PDF]

Br J Haematol
Thant MM, Gollamudi J, Benoit SW, Chonat S, Cancelas JA.   +4 more
europepmc   +1 more source

Shifting From Systemic to Precision-Targeted Complement Therapies: Opportunities and Hurdles. [PDF]

Eur J Immunol
Mannes M, Zelek WM, Trouw LA.
europepmc   +1 more source

Case Report: Avermectin poisoning-associated hemolytic uremic syndrome. [PDF]

Front Immunol
Xiao J, Shi R, Cao Q, Wang D, Wang R.
europepmc   +1 more source

Atypical hemolytic uremic syndrome in infant with solitary kidney. [PDF]

SAGE Open Med Case Rep
Collins C, Singh N.
europepmc   +1 more source